Fructose and hepatic insulin resistance.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing human studies and animal mechanistic models without systematic review methodology
PubMed 31935149 · doi:10.1080/10408363.2019.1711360
What was done
This narrative review summarizes findings from human studies and experimental animal models assessing how fructose intake leads to hepatic insulin resistance. The authors review both indirect pathways involving altered lipid metabolism and cellular stress, as well as direct disruptions of hepatic insulin signaling pathways.
What was found
The abstract reports no numerical data, effect sizes, or confidence intervals. The authors report that fructose indirectly induces hepatic insulin resistance by promoting de novo lipogenesis (DNL), impairing fatty acid oxidation (FAO), inducing endoplasmic reticulum (ER) stress, and triggering hepatic inflammation. Direct mechanisms reported include reduced expression of the insulin receptor and insulin receptor substrate 2 (IRS2), increased protein-tyrosine phosphatase 1B (PTP1b) activity, and reversal of insulin resistance upon ketohexokinase (KHK) knockdown in experimental models.
Why it matters
This synthesis argues that the fructose component of dietary sugar has distinct biochemical properties driving hepatic metabolic dysfunction beyond the effects of generic calorie-dense diets.
Limits
The abstract contains no quantitative metrics, specific human study counts, or systematic search methodology. Key molecular mechanism findings rely heavily on experimental animal models, and thresholds for dietary intake levels in humans are not defined in the abstract.
Cited by
- supports Fructose promotes liver fat accumulation while simultaneously blocking hepatic fat oxidation.